US 11026947
ALK2 inhibitors and methods for inhibiting BMP signaling
granted A61KA61K31/519A61K31/5377
Quick answer
US patent 11026947 (ALK2 inhibitors and methods for inhibiting BMP signaling) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary, Dept. of Health and Human Services
- Grant date
- Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/519, A61K31/5377, A61K31/551, A61K31/675